Polimorfismos dos genes metilenotetrahidrofolato redutase, fator de crescimento transformador β1 e linfotoxina‐α e susceptibilidade à artrite reumatoide

Revista Brasileira de Reumatologia - Tập 56 - Trang 414-420 - 2016
Olfat G. Shaker1, Amina M. Alnoury2,3, Gehan A. Hegazy2,4, Hemmat E. El Haddad5, Safaa Sayed6, Ahmed Hamdy5
1Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Cairo University, Cairo, Egito
2Clinical Biochemistry Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Arábia Saudita
3Medical Biochemistry Department, Faculty of Medicine, Ain Shams University, Cairo, Egito
4Medical Biochemistry Department, National Research Center, Cairo, Egito
5Internal Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egito
6Rheumatology & Rehabilitation Department, Faculty of Medicine, Cairo University, Cairo, Egito

Tài liệu tham khảo

Helmick, 2008, Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I, Arthritis Rheum, 58, 15, 10.1002/art.23177 Vinay, 2012, Targeting TNF superfamily members for therapeutic intervention in rheumatoid arthritis, Cytokine, 57, 305, 10.1016/j.cyto.2011.12.005 Inanir, 2013, IL‐4 and MTHFR gene polymorphism in rheumatoid arthritis and their effects, Immunol Lett., 152, 104, 10.1016/j.imlet.2013.05.004 De Mattia, 2009, C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine‐based therapy personalisation, Eur J Cancer, 45, 1333, 10.1016/j.ejca.2008.12.004 Spyridopoulou, 2012, Methylene tetrahydrofolate reductase gene polymorphisms and their association with methotrexate toxicity: a meta‐analysis, Pharmacogenet Genomics., 22, 117, 10.1097/FPC.0b013e32834ded2a Erb, 2001, Homocysteine modulation as a reason for continuous folic acid supplementation in methotrexate‐treated rheumatoid arthritis patients, Rheumatology, 40, 715, 10.1093/rheumatology/40.6.715 Epstein, 2000, Role of transforming growth factor β in human disease, N Engl J Med., 342, 1350, 10.1056/NEJM200005043421807 Evans, 1999, Gene therapy for rheumatic diseases, Arthritis Rheum, 42, 1, 10.1002/1529-0131(199901)42:1<1::AID-ANR1>3.0.CO;2-4 Aoki, 2005, Transforming growth factor beta (TGF‐beta) and autoimmunity, Autoimmun Rev, 4, 450, 10.1016/j.autrev.2005.03.006 Perricone, 2011, An overview on the genetic of rheumatoid arthritis: a never‐ending story, Autoimmun Rev, 10, 599, 10.1016/j.autrev.2011.04.021 Vasanthi, 2007, Role of tumor necrosis factor‐alpha in rheumatoid arthritis: a review, APLAR J Rheumatol., 10, 270, 10.1111/j.1479-8077.2007.00305.x Lu, 2012, A functional polymorphism of lymphotoxin‐alpha (< i> LTA</i>) gene rs909253 is associated with gastric cancer risk in an Asian population, Cancer Epidemiol., 36, e380, 10.1016/j.canep.2012.05.014 Messer, 1991, Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF‐beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF‐beta production, J Exp Med, 173, 209, 10.1084/jem.173.1.209 Partida-Rodríguez, 2010, Polymorphisms in TNF and HSP‐70 show a significant association with gastric cancer and duodenal ulcer, Int J Cancer., 126, 1861, 10.1002/ijc.24773 Sun, 2008, BAFF‐targeting therapy, a promising strategy for treating autoimmune diseases, Eur J Pharmacol, 597, 1, 10.1016/j.ejphar.2008.08.027 Wang, 2008, Osteopontin: role in immune regulation and stress responses, Cytokine Growth Factor Rev, 19, 333, 10.1016/j.cytogfr.2008.08.001 Van der Put, 1998, A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural‐tube defects?, Am J Hum Genet, 62, 1044, 10.1086/301825 Frosst, 1995, A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase, Nat Genet., 111, 10.1038/ng0595-111 Wood, 2000, Identification of human TGF‐beta1 signal (leader) sequence polymorphisms by PCR‐RFLP, J Immunol Methods, 234, 117, 10.1016/S0022-1759(99)00127-1 Vasconcelos DF, Da Silva MA, Marques MR, De Brito Junior RB, Vasconcelos AC, Barros SP. Lymphotoxin‐Alpha Gene Polymorphism +252A/G (rs909253, A/G) Is Associated with Susceptibility to Chronic Periodontitis: A Pilot Study. ISRN Dent. 2012; 2012:617245. PubMed PMID: 23050158. Pubmed Central PMCID: 3463161. Gheita, 2015, Clinical significance of serum TNFα and‐308 G/A promoter polymorphism in rheumatoid arthritis, Egypt Rheumatol., 37, 49, 10.1016/j.ejr.2014.07.001 Ismail, 2011, Possible role of leptin, and tumor necrosis factor‐alpha in hypoandrogenicity in patients with early rheumatoid arthritis, Egypt Rheumatol., 4, 209, 10.1016/j.ejr.2011.07.006 Willrich, 2015, Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases, Transl Res., 165, 270, 10.1016/j.trsl.2014.09.006 Ebrahimi, 2009, Serum levels of TNF‐alpha, TNF‐alpha RI, TNF‐alpha RII and IL‐12 in treated rheumatoid arthritis patients, Iran J Immunol, 6, 147 Ji, 2014, Serum level of osteopontin as an inflammatory marker does not indicate disease activity or responsiveness to therapeutic treatments in patients with rheumatoid arthritis, Clin Rheumatol., 33, 397, 10.1007/s10067-013-2375-3 Chen, 2010, Role of osteopontin in synovial Th17 differentiation in rheumatoid arthritis, Arthritis Rheum., 62, 2900, 10.1002/art.27603 Zhang, 2015, Role of osteopontin in rheumatoid arthritis, Rheumatol Int., 35, 589, 10.1007/s00296-014-3122-z Eldin, 2012, B‐Cell Activating Factor (BAFF) in Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Behçet's Disease, Arch Rheumatol., 27, 185 Mahdy, 2014, Therapeutic potential of hydroxychloroquine on serum B‐cell activating factor belonging to the tumor necrosis factor family (BAFF) in rheumatoid arthritis patients, Bulletin of Faculty of Pharmacy, Cairo University, 10.1016/j.bfopcu.2014.01.002 Moura, 2010, Cytokine pattern in very early rheumatoid arthritis favours B‐cell activation and survival, Rheumatology Palomino-Morales, 2010, Research article A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis, Heart Fail., 5, 2.3 Hughes, 2006, Racial or ethnic differences in allele frequencies of single‐nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis, Ann Rheum Dis., 65, 1213, 10.1136/ard.2005.046797 Rubini, 2008, The c. 1298A> C polymorphism in the methylenetetrahydrofolate reductase gene is associated with rheumatoid arthritis susceptibility in Italian patients, Clin Exp Rheumatol., 26, 163 Alayli, 2009, Association of transforming growth factor beta1 gene polymorphism with rheumatoid arthritis in a Turkish population, Joint Bone Spine, 76, 20, 10.1016/j.jbspin.2008.02.012 Zhang, 2013, Association of TGF‐β1+ 869C/T promoter polymorphism with susceptibility to autoimmune diseases: a meta‐analysis, Mol Biol Rep., 40, 4811, 10.1007/s11033-013-2577-4 Chang, 2010, Association between transforming growth factor‐β1 T869C polymorphism and rheumatoid arthritis: a meta‐analysis, Rheumatology, 49, 652, 10.1093/rheumatology/kep417 Hussein, 2014, Interaction between TGF‐β1 (869C/T) polymorphism and biochemical risk factor for prediction of disease progression in rheumatoid arthritis, Gene, 536, 393, 10.1016/j.gene.2013.11.042 Karray, 2011, Tumor necrosis factor gene polymorphisms and susceptibility to rheumatoid arthritis in regional Tunisian population, J Infect Dis Immun., 3, 30 Al-Rayes, 2011, TNF‐alpha and TNF‐beta Gene Polymorphism in Saudi Rheumatoid Arthritis Patients, Clin Med Insights Arthritis Musculoskelet Disord, 4, 55, 10.4137/CMAMD.S6941